TELADOC HEALTH, INC. Payments for Software
TELADOC HEALTH, INC. (TDOC) reported Payments for Software of $62.15 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForSoftware · last filed 2026-07-30
- TELADOC HEALTH, INC. payments for software for the quarter ending 2026-06-30 was $27.99M, a 3.37% decline year-over-year.
- TELADOC HEALTH, INC. payments for software for the quarter ending 2026-03-31 was $34.16M, a 18.38% increase year-over-year.
- TELADOC HEALTH, INC. payments for software for the quarter ending 2025-12-31 was $31.70M, a 34.82% increase year-over-year.
- TELADOC HEALTH, INC. payments for software for the quarter ending 2025-09-30 was $29.04M, a 1.74% decline year-over-year.
- TELADOC HEALTH, INC. payments for software for fiscal 2025 was $118.56M, a 4.68% increase from fiscal 2024.
- TELADOC HEALTH, INC. payments for software for fiscal 2024 was $113.26M, a 21.83% decline from fiscal 2023.
- TELADOC HEALTH, INC. payments for software for fiscal 2023 was $144.88M, a 7.29% decline from fiscal 2022.
- TELADOC HEALTH, INC. payments for software for fiscal 2022 was $156.28M, a 182.10% increase from fiscal 2021.
| Period end | Payments for Software 3 month | Payments for Software 6 month | Payments for Software 9 month | Payments for Software 12 month |
|---|---|---|---|---|
| 2026-06-30 | $27.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $62.15M 10-Q · filed 2026-07-30 | $93.85M derived: sum of 3 quarters · filed 2026-07-30 | $122.89M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $34.16M 10-Q · filed 2026-04-30 | $65.86M derived: sum of 2 quarters · filed 2026-04-30 | $94.90M derived: sum of 3 quarters · filed 2026-04-30 | $123.86M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $31.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $60.74M derived: sum of 2 quarters · filed 2026-02-26 | $89.70M derived: sum of 3 quarters · filed 2026-07-30 | $118.56M 10-K · filed 2026-02-26 |
| 2025-09-30 | $29.04M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $58.00M derived: sum of 2 quarters · filed 2026-07-30 | $86.86M 10-Q · filed 2025-10-30 | $110.37M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $28.96M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $57.82M 10-Q · filed 2026-07-30 | $81.34M derived: sum of 3 quarters · filed 2026-07-30 | $110.89M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $28.86M 10-Q · filed 2026-04-30 | $52.37M derived: sum of 2 quarters · filed 2026-04-30 | $81.92M derived: sum of 3 quarters · filed 2026-04-30 | $107.76M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $23.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $53.06M derived: sum of 2 quarters · filed 2026-02-26 | $78.90M derived: sum of 3 quarters · filed 2026-02-26 | $113.26M 10-K · filed 2026-02-26 |
| 2024-09-30 | $29.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $55.39M derived: sum of 2 quarters · filed 2025-10-30 | $89.75M 10-Q · filed 2025-10-30 | $124.85M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $25.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $60.20M 10-Q · filed 2025-07-30 | $95.30M derived: sum of 3 quarters · filed 2026-02-26 | $127.16M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $34.36M 10-Q · filed 2025-05-01 | $69.47M derived: sum of 2 quarters · filed 2026-02-26 | $101.32M derived: sum of 3 quarters · filed 2026-02-26 | $135.99M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $35.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $66.96M derived: sum of 2 quarters · filed 2026-02-26 | $101.62M derived: sum of 3 quarters · filed 2026-02-26 | $144.88M 10-K · filed 2026-02-26 |
| 2023-09-30 | $31.85M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $66.52M derived: sum of 2 quarters · filed 2024-10-31 | $109.78M 10-Q · filed 2024-10-31 | $157.48M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $34.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $77.93M 10-Q · filed 2024-08-01 | $125.62M derived: sum of 3 quarters · filed 2025-02-27 | $165.00M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $43.26M 10-Q · filed 2024-04-26 | $90.96M derived: sum of 2 quarters · filed 2025-02-27 | $130.33M derived: sum of 3 quarters · filed 2025-02-27 | $172.63M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $47.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $87.07M derived: sum of 2 quarters · filed 2025-02-27 | $129.37M derived: sum of 3 quarters · filed 2025-02-27 | $156.28M 10-K · filed 2025-02-27 |
| 2022-09-30 | $39.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-27 | $81.67M derived: sum of 2 quarters · filed 2023-10-27 | $108.59M 10-Q · filed 2023-10-27 | $128.59M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-06-30 | $42.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | $69.21M 10-Q · filed 2023-07-28 | $89.21M derived: sum of 3 quarters · filed 2024-02-23 | $103.11M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-03-31 | $26.92M 10-Q · filed 2023-05-02 | $46.92M derived: sum of 2 quarters · filed 2024-02-23 | $60.81M derived: sum of 3 quarters · filed 2024-02-23 | $71.17M derived: sum of 4 quarters · filed 2024-02-23 |
| 2021-12-31 | $20.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $33.89M derived: sum of 2 quarters · filed 2024-02-23 | $44.26M derived: sum of 3 quarters · filed 2024-02-23 | $55.40M 10-K · filed 2024-02-23 |
| 2021-09-30 | $13.89M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $24.26M derived: sum of 2 quarters · filed 2022-11-02 | $35.40M 10-Q · filed 2022-11-02 | |
| 2021-06-30 | $10.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $21.51M 10-Q · filed 2022-08-03 | ||
| 2021-03-31 | $11.14M 10-Q · filed 2022-05-02 | |||
| 2020-12-31 | $22.02M 10-K · filed 2023-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SBC Medical Group Holdings Inc (SBC) | United States | $0.487B | |
| Airsculpt Technologies, Inc. (AIRS) | United States | $0.146B | -27.36 |
| LifeMD, Inc. (LFMD) | United States | $0.141B | 982.53 |